Llwytho...
Systematic review and meta-analysis of the risk of rheumatoid arthritis-associated interstitial lung disease related to anti-cyclic citrullinated peptide (CCP) antibody
OBJECTIVE: To clarify the risk of rheumatoid arthritis-associated interstitial lung disease (RA-ILD) related to anti-cyclic citrullinated peptide (CCP) antibody. ELIGIBILITY CRITERIA: Patients with RA with and without ILD were eligible. The primary outcome was the prevalence or incidence of ILD. Pri...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | BMJ Open |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
BMJ Publishing Group
2021
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8016072/ https://ncbi.nlm.nih.gov/pubmed/33789847 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-040465 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|